Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash Flows From Operating Activities:    
Net (loss) income $ (176,808) $ 285,270
Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities:    
Amortization of premiums and discounts on investment securities, net 7,978 32,504
Amortization of deferred debt issuance costs on term notes payable and convertible senior notes 659 648
(Reversal of) provision for credit losses on investment securities (142) 1,114
Realized and unrealized (gains) losses on investment securities (10,656) 51,228
Loss (gain) on servicing asset 28,079 (410,624)
Realized and unrealized loss on interest rate swaps and swaptions 85,765 37,300
Unrealized losses (gains) on other derivative instruments 67,484 (90,261)
Equity based compensation 6,052 4,161
Net change in assets and liabilities:    
(Increase) decrease in accrued interest receivable (4,808) 1,106
(Increase) decrease in deferred income taxes, net (5,997) 48,798
Decrease in accrued interest payable (19,118) (8,391)
Change in other operating assets and liabilities, net 21,627 (4,198)
Net cash provided by (used in) operating activities 115 (51,345)
Cash Flows From Investing Activities:    
Purchases of available-for-sale securities (2,553,519) (2,609,992)
Proceeds from sales of available-for-sale securities 1,360,742 2,012,620
Principal payments on available-for-sale securities 139,442 371,666
Purchases of mortgage servicing rights, net of purchase price adjustments (117,441) (487,761)
Proceeds from sales of mortgage servicing rights 1,854 0
(Purchases) short sales of derivative instruments, net (227) 40,998
(Payments for termination and settlement) proceeds from sales and settlement of derivative instruments, net (224,952) 107,472
Payments for reverse repurchase agreements (966,485) (381,280)
Proceeds from reverse repurchase agreements 1,549,504 377,337
Decrease in due to counterparties, net (258,903) (142,589)
Net cash used in investing activities (1,069,985) (711,529)
Cash Flows From Financing Activities:    
Proceeds from repurchase agreements 11,321,136 7,955,364
Principal payments on repurchase agreements (10,839,435) (7,739,153)
Proceeds from revolving credit facilities 174,000 150,000
Repayment of convertible senior notes 0 (143,774)
Proceeds from issuance of common stock, net of offering costs 177,729 323
Dividends paid on preferred stock (12,365) (13,747)
Dividends paid on common stock (52,139) (58,665)
Net cash provided by financing activities 768,926 150,348
Net decrease in cash, cash equivalents and restricted cash (300,944) (612,526)
Cash, cash equivalents and restricted cash at beginning of period 1,126,505 2,088,670
Cash, cash equivalents and restricted cash at end of period 825,561 1,476,144
Supplemental Disclosure of Cash Flow Information:    
Cash paid for interest 153,280 25,750
Cash paid (received) for taxes, net 42 (32)
Noncash Activities:    
Dividends declared but not paid at end of period $ 70,746 $ 72,558